2025-06-24 |
2025-06-24 |
V
Verkauf
|
Saik Andrew
Chief Financial Officer
Führungsperson
|
1.000
-3.4%
7,61
43.377 USD
|
1.000
-3.4%
|
7,61
|
100.000 USD
|
|
2025-06-18 |
2025-06-17 |
V
Verkauf
|
Cacace Angela M
Chief Scientific Officer
Führungsperson
|
1.000
-1.6%
7,49
19.347 USD
|
1.000
-1.6%
|
7,49
|
100.000 USD
|
|
2025-03-19 |
2025-03-18 |
V
Verkauf
|
Berkowitz Noah
Chief Medical Officer
Führungsperson
|
8.658
-7.3%
8,59
74.372 USD
|
8.658
-7.3%
|
8,59
|
74.372 USD
|
|
2025-02-25 |
2025-02-24 |
V
Verkauf
|
Cacace Angela M
Chief Scientific Officer
Führungsperson
|
1.146
-1.2%
16,55
18.966 USD
|
1.146
-1.2%
|
16,55
|
18.966 USD
|
|
2025-02-25 |
2025-02-24 |
V
Verkauf
|
Cacace Angela M
Chief Scientific Officer
Führungsperson
|
3.061
-3.0%
16,75
51.272 USD
|
3.061
-3.0%
|
16,75
|
51.272 USD
|
|
2025-02-25 |
2025-02-24 |
V
Verkauf
|
Houston John G
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
5.154
-0.4%
16,55
85.299 USD
|
5.154
-0.4%
|
16,55
|
85.299 USD
|
|
2025-02-25 |
2025-02-24 |
V
Verkauf
|
Houston John G
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
26.184
-2.2%
16,75
438.582 USD
|
26.184
-2.2%
|
16,75
|
438.582 USD
|
|
2025-02-25 |
2025-02-24 |
V
Verkauf
|
Loomis David K
Chief Accounting Officer
Führungsperson
|
1.214
-6.0%
16,75
20.335 USD
|
1.214
-6.0%
|
16,75
|
20.335 USD
|
|
2025-02-25 |
2025-02-24 |
V
Verkauf
|
Taylor Ian
President, R&D
Führungsperson
|
1.664
-1.0%
16,55
27.539 USD
|
1.664
-1.0%
|
16,55
|
27.539 USD
|
|
2025-02-25 |
2025-02-24 |
V
Verkauf
|
Taylor Ian
President, R&D
Führungsperson
|
7.356
-4.4%
16,75
123.213 USD
|
7.356
-4.4%
|
16,75
|
123.213 USD
|
|
2024-11-12 |
2024-11-07 |
V
Verkauf
|
Loomis David K
Chief Accounting Officer
Führungsperson
|
231
-2.8%
27,69
6.396 USD
|
231
-2.8%
|
27,69
|
6.396 USD
|
|
2024-02-27 |
2024-02-23 |
V
Verkauf
|
Peck Ronald
Chief Medical Officer
Führungsperson
|
1.699
-2.5%
47,05
79.938 USD
|
1.699
-2.5%
|
47,05
|
79.938 USD
|
|
2024-02-27 |
2024-02-23 |
V
Verkauf
|
Houston John G
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
5.196
-0.5%
47,05
244.472 USD
|
5.196
-0.5%
|
47,05
|
244.472 USD
|
|
2024-02-27 |
2024-02-23 |
V
Verkauf
|
Cassidy Sean A
Chief Financial Officer
Führungsperson
|
1.702
-0.9%
47,05
80.079 USD
|
1.702
-0.9%
|
47,05
|
80.079 USD
|
|
2024-02-27 |
2024-02-23 |
V
Verkauf
|
Taylor Ian
Chief Scientific Officer
Führungsperson
|
1.701
-1.1%
47,05
80.032 USD
|
1.701
-1.1%
|
47,05
|
80.032 USD
|
|
2024-11-12 |
2023-11-08 |
V
Verkauf
|
Loomis David K
Chief Accounting Officer
Führungsperson
|
229
-2.7%
17,05
3.904 USD
|
229
-2.7%
|
17,05
|
3.904 USD
|
|
2023-08-14 |
2023-08-11 |
V
Verkauf
|
Peck Ronald
Chief Medical Officer
Führungsperson
|
1.324
-4.2%
24,39
32.289 USD
|
1.324
-4.2%
|
24,39
|
32.289 USD
|
|
2023-03-03 |
2023-03-01 |
V
Verkauf
|
Houston John G
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
5.878
-0.6%
29,53
173.577 USD
|
5.878
-0.6%
|
29,53
|
173.577 USD
|
|
2023-03-03 |
2023-03-01 |
V
Verkauf
|
Cassidy Sean A
Chief Financial Officer
Führungsperson
|
1.745
-0.9%
29,53
51.530 USD
|
1.745
-0.9%
|
29,53
|
51.530 USD
|
|
2023-03-03 |
2023-03-01 |
V
Verkauf
|
Taylor Ian
Chief Scientific Officer
Führungsperson
|
1.051
-1.0%
29,53
31.036 USD
|
1.051
-1.0%
|
29,53
|
31.036 USD
|
|